Before therapy, patients with MG showed a reduction in the frequency of chemokine receptor 3 (CXCR3)+ CD4+ T cells, especially in the thymoma group; however, CXCR3+ CD8+ T cells remained normal. This evidence concerns the gene CXCR3 and myasthenia gravis.